Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona

Detalhes bibliográficos
Ano de defesa: 2019
Autor(a) principal: Duarte, Thiago lattes
Orientador(a): Cruz, Ivana Beatrice Mânica da lattes
Banca de defesa: Bauermann, Liliane de Freitas lattes, Bica, Cláudia Giuliano lattes, Montano, Marco Aurélio Echart, Royes, Luiz Fernando Freire
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Centro de Ciências da Saúde
Programa de Pós-Graduação: Programa de Pós-Graduação em Farmacologia
Departamento: Ciências da Saúde
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.ufsm.br/handle/1/20917
Resumo: Antipsychotics (APs) are used to treat schizophrenia and other psychiatric disorders. Most of these medications have adverse effects causing obesity and metabolic changes associated with oxidative stress and inflammation. Studies have reported that Ziprasidone (ZIP), unlike other APs, can cause the same effects in an attenuated manner, as well as allergic responses. Currently, the cause of the effects triggered by ZIP is not well characterized and some patients do not respond satisfactorily to the treatment, perhaps due to the influence of genetic polymorphisms. The action of the Val16AlaSOD2 polymorphism causes a superoxide-hydrogen peroxide (S-HP) imbalance, which is involved with oxidative-inflammatory metabolism. Bioactive molecules present in foods such as xanthines and catechins have an anti-inflammatory and antioxidant effect that may influence the attenuation of the adverse effects triggered by this drug. In order to better understand this information, this study investigated the in vitro effect of ZIP on the oxidative-inflammatory response of immune cells by evaluating the potential influence of the Val16Ala-SOD2 polymorphism and the guarana chemical matrix in the form of three experimental designs. In the first, we analyzed the in vitro effect of ZIP on the oxidative-inflammatory response of RAW 264.7 macrophages exposed to different ZIP concentrations (18.5, 37.5, 75, 150, 300 μg / mL) using phytohemagglutinin (PHA) as a positive control inflammation and lithium (Li) as a negative control through its action on the rate of cell proliferation, cell cycle, modulation of oxidative markers related to immune response, modulation of proinflammatory and anti- inflammatory cytokines and modulation of the gene expression of these cytokines via the qRT-PCR technique. The second in vitro protocol was conducted using peripheral blood mononuclear cells (PBMCs) obtained from healthy donors bearing different Val16Ala-SOD2 polymorphism genotypes exposed to ZIP in 72h cell culture. The previously mentioned markers were then measured, including levels of lipoperoxidative markers and DNA damage. The third protocol evaluated the effect of the xanthine-catechin (XC-Mix) chemical matrix of guarana powder that presents bioactive molecules in the modulation of the oxidative-inflammatory response triggered by ZIP on RAW 264.7 macrophages. The first study showed that in non-activated macrophages exposed to ZIP, there was induction of inflammatory response represented by macrophage spreading, increased cell proliferation, elevated levels of oxidant molecules and pro-inflammatory cytokines, and reduction of the anti-inflammatory cytokine as well as regulation and gene expression of all cytokines. The second study demonstrated a possible pharmacogenomic action of the Val16Ala-SOD2 polymorphism where CMSPs linked to the AA genotype exposed to the ZIP showed an increase of the basal levels of H2O2 evidencing a possible genotoxic effect while PBMCs linked to the VV genotype showed high levels of proinflammatory cytokines. The third protocol showed that XC-Mix supplementation promoted a reduction effect on cell proliferation and decreased levels of inflammatory, oxidative and genotoxic markers, contributing to the modulation and increase of anti-inflammatory cytokine levels. All of the described results show, despite the methodological limitations, a possible influence of the polymorphism on the adverse effects triggered by the ZIP and that the chemical matrix of guarana powder can guarantee anti-inflammatory and antioxidant effects. The results become relevant in the psychiatric clinic by opening the possibility of personalizing antipsychotic therapy as well as stimulating research for the development of alternative methods for the treatment of associated metabolic disorders.
id UFSM_641ad89537e174f584a76dea9100b55b
oai_identifier_str oai:repositorio.ufsm.br:1/20917
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2021-05-18T17:14:07Z2021-05-18T17:14:07Z2019-03-12http://repositorio.ufsm.br/handle/1/20917Antipsychotics (APs) are used to treat schizophrenia and other psychiatric disorders. Most of these medications have adverse effects causing obesity and metabolic changes associated with oxidative stress and inflammation. Studies have reported that Ziprasidone (ZIP), unlike other APs, can cause the same effects in an attenuated manner, as well as allergic responses. Currently, the cause of the effects triggered by ZIP is not well characterized and some patients do not respond satisfactorily to the treatment, perhaps due to the influence of genetic polymorphisms. The action of the Val16AlaSOD2 polymorphism causes a superoxide-hydrogen peroxide (S-HP) imbalance, which is involved with oxidative-inflammatory metabolism. Bioactive molecules present in foods such as xanthines and catechins have an anti-inflammatory and antioxidant effect that may influence the attenuation of the adverse effects triggered by this drug. In order to better understand this information, this study investigated the in vitro effect of ZIP on the oxidative-inflammatory response of immune cells by evaluating the potential influence of the Val16Ala-SOD2 polymorphism and the guarana chemical matrix in the form of three experimental designs. In the first, we analyzed the in vitro effect of ZIP on the oxidative-inflammatory response of RAW 264.7 macrophages exposed to different ZIP concentrations (18.5, 37.5, 75, 150, 300 μg / mL) using phytohemagglutinin (PHA) as a positive control inflammation and lithium (Li) as a negative control through its action on the rate of cell proliferation, cell cycle, modulation of oxidative markers related to immune response, modulation of proinflammatory and anti- inflammatory cytokines and modulation of the gene expression of these cytokines via the qRT-PCR technique. The second in vitro protocol was conducted using peripheral blood mononuclear cells (PBMCs) obtained from healthy donors bearing different Val16Ala-SOD2 polymorphism genotypes exposed to ZIP in 72h cell culture. The previously mentioned markers were then measured, including levels of lipoperoxidative markers and DNA damage. The third protocol evaluated the effect of the xanthine-catechin (XC-Mix) chemical matrix of guarana powder that presents bioactive molecules in the modulation of the oxidative-inflammatory response triggered by ZIP on RAW 264.7 macrophages. The first study showed that in non-activated macrophages exposed to ZIP, there was induction of inflammatory response represented by macrophage spreading, increased cell proliferation, elevated levels of oxidant molecules and pro-inflammatory cytokines, and reduction of the anti-inflammatory cytokine as well as regulation and gene expression of all cytokines. The second study demonstrated a possible pharmacogenomic action of the Val16Ala-SOD2 polymorphism where CMSPs linked to the AA genotype exposed to the ZIP showed an increase of the basal levels of H2O2 evidencing a possible genotoxic effect while PBMCs linked to the VV genotype showed high levels of proinflammatory cytokines. The third protocol showed that XC-Mix supplementation promoted a reduction effect on cell proliferation and decreased levels of inflammatory, oxidative and genotoxic markers, contributing to the modulation and increase of anti-inflammatory cytokine levels. All of the described results show, despite the methodological limitations, a possible influence of the polymorphism on the adverse effects triggered by the ZIP and that the chemical matrix of guarana powder can guarantee anti-inflammatory and antioxidant effects. The results become relevant in the psychiatric clinic by opening the possibility of personalizing antipsychotic therapy as well as stimulating research for the development of alternative methods for the treatment of associated metabolic disorders.Os antipsicóticos (APs) são usados para tratar a esquizofrenia e outros distúrbios psiquiátricos. A maioria destes medicamentos apresentam efeitos adversos causando obesidade e alterações metabólicas associadas ao estresse oxidativo e inflamação. Estudos relatam que a Ziprasidona (ZIP) diferentemente de outros APs, pode causar os mesmos efeitos de maneira atenuada, bem como respostas alérgicas. Atualmente, a causa dos efeitos desencadeados pela ZIP não está bem caracterizada e alguns pacientes não respondem satisfatoriamente ao tratamento talvez pela influência de polimorfismos genéticos. A ação do polimorfismo Val16AlaSOD2 causa um desbalanço superóxido-peróxido de hidrogênio (S-HP), o qual está envolvido com o metabolismo oxidativo-inflamatório. Moléculas bioativas presentes nos alimentos como xantinas e catequinas possuem efeito anti-inflamatório e antioxidante que podem influenciar na atenuação dos efeitos adversos desencadeados por este fármaco. Afim de compreender melhor estas informações, este estudo investigou o efeito in vitro da ZIP na resposta oxidativo-inflamatória de células imunes avaliando a potencial influência do polimorfismo Val16Ala-SOD2 e da matriz química do guaraná no mesmo na forma de três delineamentos experimentais conduzidos. No primeiro foi analisado o efeito in vitro da ZIP na resposta oxidativo-inflamatória de macrófagos RAW 264.7 expostos a diferentes concentrações de ZIP (18.5, 37.5, 75, 150, 300 µg/mL) utilizando-se a fitohemaglutinina (PHA) como controle positivo de inflamação e o lítio (Li) como controle negativo através de sua ação na taxa de proliferação celular, no ciclo celular, na modulação de marcadores oxidativos relacionados a resposta imune, na modulação dos níveis das citocinas pró- inflamatórias e anti-inflamatória e na modulação da expressão gênica destas citocinas via técnica qRT-PCR. O segundo protocolo in vitro foi conduzido utilizando células mononucleares de sangue periférico (CMSPs) obtidas de doadores saudáveis portadores de diferentes genótipos do polimorfismo Val16Ala-SOD2 expostas a ZIP em cultura celular de 72h. Posteriormente mensurou-se os marcadores anteriormente citados incluindo os níveis de marcadores lipoperoxidativos e de dano ao DNA. O terceiro protocolo avaliou o efeito da matriz química de xantina-catequina (XC-Mix) do pó de guaraná que apresenta moléculas bioativas na modulação da resposta oxidativo-inflamatória desencadeada pela ZIP em macrófagos RAW 264.7. O primeiro estudo mostrou que em macrófagos não ativados expostos à ZIP, houve indução de resposta inflamatória representada pelo espraiamento de macrófagos, aumento da proliferação celular, elevação dos níveis de moléculas oxidantes e das citocinas pró-inflamatórias e redução da citocina anti-inflamatória assim como regulação e expressão gênica de todas as citocinas. O segundo estudo demonstrou uma possível ação farmacogenômica do polimorfismo Val16Ala- SOD2 onde CMSPs ligadas ao genótipo AA expostas à ZIP apresentaram aumento dos níveis basais de H2O2 evidenciando um possível efeito genotóxico enquanto CMSPs ligadas ao genótipo VV apresentaram altos níveis de citocinas pró-inflamatórias. O terceiro protocolo evidenciou que a suplementação isolada e do XC-Mix promoveram efeito redutor na proliferação celular e diminuição dos níveis de marcadores inflamatórios, oxidativos e genotóxicos, contribuindo na modulação e no aumento dos níveis de citocina anti-inflamatória. O conjunto dos resultados descritos mostram apesar das limitações metodológicas, uma possível influência do polimorfismo em efeitos adversos desencadeados pela ZIP e que a matriz química do pó de guaraná pode garantir efeitos anti-inflamatórios e antioxidantes. Os resultados tornam-se relevantes na clínica psiquiátrica abrindo a possibilidade da personalização da terapia antipsicótica assim como também estimula pesquisas para o desenvolvimento de métodos alternativos para o tratamento de distúrbios metabólicos associados.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilCiências da SaúdeAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessEsquizofreniaPolimorfismo Val16Ala-SOD2ZiprasidonaInfllamaçãoEstresse oxidativoGuaranáSchizophreniaPolymorphism Val16Ala-SOD2ZiprasidoneInflammationOxidative stressGuaranaCNPQ::CIENCIAS DA SAUDE::FARMACIAInfluência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidonaInfluence of Val16Ala-SOD2 genetic polymorphism and the guaraná chemical matrix in the oxidative and inflammatory state in vitro of ziprasidone chloridateinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisCruz, Ivana Beatrice Mânica dahttp://lattes.cnpq.br/3426369324110716Bauermann, Liliane de FreitasXXXXXXXXXXXXXXXBica, Cláudia GiulianoXXXXXXXXXXXXXXXXXXMontano, Marco Aurélio EchartXXXXXXXXXXXXXXXRoyes, Luiz Fernando FreireXXXXXXXXXXXXXXXXXXhttp://lattes.cnpq.br/8992476216968942Duarte, Thiago4003000000056000b5fcfe0-b017-4163-80e2-17c110fbcf0134af4ef6-74e0-4bf2-9511-f4d8fe5331dcf89660ad-570e-4c5a-95c8-8554d6a597313398c6f5-b975-44ea-ad32-8a03e1765ffd8e53c486-3dfc-42a9-85d5-f7e237ce0cdb606a5885-4038-438d-8b9d-cec2378006a1reponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdfTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdfTese de Doutoradoapplication/pdf3941057http://repositorio.ufsm.br/bitstream/1/20917/1/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf9e06f8e1210221c6904a8e1c631fce45MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/20917/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/20917/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53TEXTTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.txtTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.txtExtracted texttext/plain344323http://repositorio.ufsm.br/bitstream/1/20917/4/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.txt40f628af56cb4ace39b87a30a2f80a29MD54THUMBNAILTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.jpgTES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.jpgIM Thumbnailimage/jpeg4586http://repositorio.ufsm.br/bitstream/1/20917/5/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.jpg4f3e17526d84c9e44ffd2167735464a4MD551/209172021-05-19 03:03:05.024oai:repositorio.ufsm.br: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 Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2021-05-19T06:03:05Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
dc.title.alternative.eng.fl_str_mv Influence of Val16Ala-SOD2 genetic polymorphism and the guaraná chemical matrix in the oxidative and inflammatory state in vitro of ziprasidone chloridate
title Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
spellingShingle Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
Duarte, Thiago
Esquizofrenia
Polimorfismo Val16Ala-SOD2
Ziprasidona
Infllamação
Estresse oxidativo
Guaraná
Schizophrenia
Polymorphism Val16Ala-SOD2
Ziprasidone
Inflammation
Oxidative stress
Guarana
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
title_full Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
title_fullStr Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
title_full_unstemmed Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
title_sort Influência do polimorfismo genético Val16Ala-SOD2 e da matriz química do guaraná no estado oxidativo-inflamatório in vitro do cloridrato de ziprasidona
author Duarte, Thiago
author_facet Duarte, Thiago
author_role author
dc.contributor.advisor1.fl_str_mv Cruz, Ivana Beatrice Mânica da
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/3426369324110716
dc.contributor.referee1.fl_str_mv Bauermann, Liliane de Freitas
dc.contributor.referee1Lattes.fl_str_mv XXXXXXXXXXXXXXX
dc.contributor.referee2.fl_str_mv Bica, Cláudia Giuliano
dc.contributor.referee2Lattes.fl_str_mv XXXXXXXXXXXXXXXXXX
dc.contributor.referee3.fl_str_mv Montano, Marco Aurélio Echart
dc.contributor.referee3Lattes.fl_str_mv XXXXXXXXXXXXXXX
dc.contributor.referee4.fl_str_mv Royes, Luiz Fernando Freire
dc.contributor.referee4Lattes.fl_str_mv XXXXXXXXXXXXXXXXXX
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/8992476216968942
dc.contributor.author.fl_str_mv Duarte, Thiago
contributor_str_mv Cruz, Ivana Beatrice Mânica da
Bauermann, Liliane de Freitas
Bica, Cláudia Giuliano
Montano, Marco Aurélio Echart
Royes, Luiz Fernando Freire
dc.subject.por.fl_str_mv Esquizofrenia
Polimorfismo Val16Ala-SOD2
Ziprasidona
Infllamação
Estresse oxidativo
Guaraná
topic Esquizofrenia
Polimorfismo Val16Ala-SOD2
Ziprasidona
Infllamação
Estresse oxidativo
Guaraná
Schizophrenia
Polymorphism Val16Ala-SOD2
Ziprasidone
Inflammation
Oxidative stress
Guarana
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Schizophrenia
Polymorphism Val16Ala-SOD2
Ziprasidone
Inflammation
Oxidative stress
Guarana
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Antipsychotics (APs) are used to treat schizophrenia and other psychiatric disorders. Most of these medications have adverse effects causing obesity and metabolic changes associated with oxidative stress and inflammation. Studies have reported that Ziprasidone (ZIP), unlike other APs, can cause the same effects in an attenuated manner, as well as allergic responses. Currently, the cause of the effects triggered by ZIP is not well characterized and some patients do not respond satisfactorily to the treatment, perhaps due to the influence of genetic polymorphisms. The action of the Val16AlaSOD2 polymorphism causes a superoxide-hydrogen peroxide (S-HP) imbalance, which is involved with oxidative-inflammatory metabolism. Bioactive molecules present in foods such as xanthines and catechins have an anti-inflammatory and antioxidant effect that may influence the attenuation of the adverse effects triggered by this drug. In order to better understand this information, this study investigated the in vitro effect of ZIP on the oxidative-inflammatory response of immune cells by evaluating the potential influence of the Val16Ala-SOD2 polymorphism and the guarana chemical matrix in the form of three experimental designs. In the first, we analyzed the in vitro effect of ZIP on the oxidative-inflammatory response of RAW 264.7 macrophages exposed to different ZIP concentrations (18.5, 37.5, 75, 150, 300 μg / mL) using phytohemagglutinin (PHA) as a positive control inflammation and lithium (Li) as a negative control through its action on the rate of cell proliferation, cell cycle, modulation of oxidative markers related to immune response, modulation of proinflammatory and anti- inflammatory cytokines and modulation of the gene expression of these cytokines via the qRT-PCR technique. The second in vitro protocol was conducted using peripheral blood mononuclear cells (PBMCs) obtained from healthy donors bearing different Val16Ala-SOD2 polymorphism genotypes exposed to ZIP in 72h cell culture. The previously mentioned markers were then measured, including levels of lipoperoxidative markers and DNA damage. The third protocol evaluated the effect of the xanthine-catechin (XC-Mix) chemical matrix of guarana powder that presents bioactive molecules in the modulation of the oxidative-inflammatory response triggered by ZIP on RAW 264.7 macrophages. The first study showed that in non-activated macrophages exposed to ZIP, there was induction of inflammatory response represented by macrophage spreading, increased cell proliferation, elevated levels of oxidant molecules and pro-inflammatory cytokines, and reduction of the anti-inflammatory cytokine as well as regulation and gene expression of all cytokines. The second study demonstrated a possible pharmacogenomic action of the Val16Ala-SOD2 polymorphism where CMSPs linked to the AA genotype exposed to the ZIP showed an increase of the basal levels of H2O2 evidencing a possible genotoxic effect while PBMCs linked to the VV genotype showed high levels of proinflammatory cytokines. The third protocol showed that XC-Mix supplementation promoted a reduction effect on cell proliferation and decreased levels of inflammatory, oxidative and genotoxic markers, contributing to the modulation and increase of anti-inflammatory cytokine levels. All of the described results show, despite the methodological limitations, a possible influence of the polymorphism on the adverse effects triggered by the ZIP and that the chemical matrix of guarana powder can guarantee anti-inflammatory and antioxidant effects. The results become relevant in the psychiatric clinic by opening the possibility of personalizing antipsychotic therapy as well as stimulating research for the development of alternative methods for the treatment of associated metabolic disorders.
publishDate 2019
dc.date.issued.fl_str_mv 2019-03-12
dc.date.accessioned.fl_str_mv 2021-05-18T17:14:07Z
dc.date.available.fl_str_mv 2021-05-18T17:14:07Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/20917
url http://repositorio.ufsm.br/handle/1/20917
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 400300000005
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 0b5fcfe0-b017-4163-80e2-17c110fbcf01
34af4ef6-74e0-4bf2-9511-f4d8fe5331dc
f89660ad-570e-4c5a-95c8-8554d6a59731
3398c6f5-b975-44ea-ad32-8a03e1765ffd
8e53c486-3dfc-42a9-85d5-f7e237ce0cdb
606a5885-4038-438d-8b9d-cec2378006a1
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/20917/1/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf
http://repositorio.ufsm.br/bitstream/1/20917/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/20917/3/license.txt
http://repositorio.ufsm.br/bitstream/1/20917/4/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.txt
http://repositorio.ufsm.br/bitstream/1/20917/5/TES_PPGFARMACOLOGIA_2019_DUARTE_THIAGO.pdf.jpg
bitstream.checksum.fl_str_mv 9e06f8e1210221c6904a8e1c631fce45
4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
40f628af56cb4ace39b87a30a2f80a29
4f3e17526d84c9e44ffd2167735464a4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1793240128901087232